Avanos Medical AVNS PM&R — Advertising, promotion and selling expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept avns:AdvertisingPromotionAndSellingExpenses.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's pm&r — advertising, promotion and selling expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's PM&R — advertising, promotion and selling expenses?
- Avanos Medical (AVNS) reported PM&R — advertising, promotion and selling expenses of -$15.9M in Q1 2026.
- How has Avanos Medical's PM&R — advertising, promotion and selling expenses changed year-over-year?
- Avanos Medical's PM&R — advertising, promotion and selling expenses decreased by 6.7% year-over-year, from -$14.9M to -$15.9M.
- What is the long-term trend for Avanos Medical's PM&R — advertising, promotion and selling expenses?
- Over 2 years (2023 to 2025), Avanos Medical's PM&R — advertising, promotion and selling expenses has grown at a -9.0% compound annual growth rate (CAGR), from -$75.2M to -$62.3M.
- What does PM&R — advertising, promotion and selling expenses mean?
- Represents the costs incurred to market, promote, and sell products within the Pain Management and Recovery segment, including sales force compensation and promotional activities. This metric is essential for evaluating the commercial effectiveness and customer acquisition costs of the segment.